Earable Neuroscience and Excelpoint Partner to Commercialize AI-Powered FRENZ Brainband for Global Sleep Pandemic

31 March 2023 | Friday | News


Earable® Neuroscience U.S. ("Earable®"), is pleased to announce a strategic partnership with Singapore-based Excelpoint Technology Pte. Ltd., ("Excelpoint") to accelerate the commercialisation of the world's first AI-powered consumer wearable, FRENZ™ Brainband, which tracks and stimulates brain activities to enhance mental well-being through improvements in sleep, relaxation and focus.
 Mr. Tam Vu - CEO of Earable Neuroscience U.S. on the left, and Mr. Albert Phuay - Chairman of Excelpoint on the right - shared their visions in making positive impacts for human wellbeing

Mr. Tam Vu - CEO of Earable Neuroscience U.S. on the left, and Mr. Albert Phuay - Chairman of Excelpoint on the right - shared their visions in making positive impacts for human wellbeing

  • Since the COVID-19 pandemic began, researchers around the world have documented a surge in sleep disorders which affect overall health, safety and quality of life
  • Invented by Earable® Neuroscience, FRENZ™ Brainband is the world's first AI-powered consumer wearable that tracks and stimulates brain activities to enhance mental well-being through improvements in sleep, relaxation and focus
  • With its leading regional B2B business platform that provides quality electronics components with integrated R&D capabilities, Excelpoint will be the exclusive procurement partner for the electronics components used for the production of FRENZ™ Brainband
  • At the same time, PlanetSpark, the entrepreneurial and strategic investment arm of Excelpoint, is currently exploring its options to make an investment in Earable® Neuroscience

FRENZ™ Brainband can precisely tracks vital data points in real-time, provides instant personalized feedback with cognitive behavioral therapy content via the integrated bone-conduction speakers, and leverages AI and machine learning algorithms to continuously evolve and provide meaningful insights to enhance mental well-being for individuals.

Since the COVID-19 pandemic began, researchers around the world have documented a surge in sleep disorders which affect overall health, safety and quality of life.

Powered by proprietary technologies, FRENZ™ Brainband is an invention of Earable® Neuroscience, founded by Dr Tam Vu, a scientist and professor with lifelong research in neuroscience and computer science, is a deep tech company focused on delivering scalable, human-centric neuroscience solutions that improve the everyday experience — from deep sleep to all-day focus.

With eight years of intensive deep tech R&D by scientists from the University of Colorado Boulder and University of Oxford, FRENZ™ Brainband holds 15 global patents in machine learning algorithms, materials science, and electrical engineering. FRENZ™ Brainband has been accorded multiple awards in various international technology and design competitions, marking its position as the world's first AI-powered consumer head wearable dedicated for improving quality of sleep and cognitive functions.

Singapore-based Excelpoint was established in 1987 and it has grown into a leading regional electronics components distributor providing quality electronic components from leading electronics group such as ADI, Xilinx, NXP, Samsung, Qualcomm, Panasonic, Fujitsu, TDK, and Epson, among others as well as engineering design services and supply chain management to original equipment manufacturers ("OEMs"), ODMs and electronics manufacturing services ("EMS") in the Asia Pacific region. Excelpoint is also the authorised distributor of Qualcomm in ASEAN, India, Australia and New Zealand.

Strategic Partnership of Earable® Neuroscience and Excelpoint to Accelerate the Commercialisation of FRENZ™ Brainband

Combined with its neuroscience data platform, Earable® Neuroscience is at the final stage of commercialisingFRENZ™ Brainband.

The main goal of the strategic partnership between Earable® Neuroscience and Excelpoint is for both companies to leverage on each other's capabilities and networks to accelerate the commericalisation of FRENZ™ Brainband, thereby enabling an entirely new world of possibilities for neuroscience applications.

As part of the strategic partnership, Excelpoint will be the exclusive procurement partner for the electronics components used for the production of FRENZ™ Brainband. In addition, Excelpoint will provide favorable procurement terms to support Earable® Neuroscience so as to accelerate the commercialisation phase of FRENZ™ Brainband.

At the same time, PlanetSpark Pte. Ltd., ("PlanetSpark") the entrepreneurial and strategic investment arm of Excelpoint, is currently exploring its options to make an investment in Earable® Neuroscience.

Commenting on the strategic partnership, Dr. Tam Vu, Founder and CEO of Earable® Neuroscience, said: "Earable® Neuroscience's vision is to make the daily benefits of neuroscience accessible to billions of people to enhance their cognitive functions and unlock the brain's potential, improving productivity, mental wellbeing, and quality of life.

Excelpoint's global expertise and ecosystem in electronic components and supply chain management makes them the ideal partner to help us to secure the scalability of this vision."

Mr. Albert Phuay, Chairman of Excelpoint added, "We share Earable® Neuroscience aspirations to drive innovation in the field of disruptive sleeptech and we are thrilled with this partnership to accelerate the commercialisation of FRENZ™ Brainband to new levels of growth and expansion.

We believe that Earable®'s advanced neuroscience expertise, combined with our ecosystem will enable us to scale up the production of high-quality and cutting-edge sleeptech products that make a meaningful impact in the lives of people around the world."

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close